R. Shorthouse

536 total citations
12 papers, 437 citations indexed

About

R. Shorthouse is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, R. Shorthouse has authored 12 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Organic Chemistry. Recurrent topics in R. Shorthouse's work include Transplantation: Methods and Outcomes (6 papers), Tracheal and airway disorders (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). R. Shorthouse is often cited by papers focused on Transplantation: Methods and Outcomes (6 papers), Tracheal and airway disorders (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). R. Shorthouse collaborates with scholars based in United States, Spain and United Kingdom. R. Shorthouse's co-authors include Randall E. Morris, Xinfan Huang, Clare R. Gregory, Margaret E. Billingham, Richard E. Pratt, Victor J. Dzau, Gerald J. Berry, Tim Brazelton, Timothy R. Brazelton and Tuija Ikonen and has published in prestigious journals such as Transplantation, Transplantation Proceedings and PubMed.

In The Last Decade

R. Shorthouse

12 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Shorthouse United States 9 293 171 123 67 44 12 437
Gerold Becker Germany 9 176 0.6× 124 0.7× 37 0.3× 51 0.8× 58 1.3× 24 460
Catherine Bonvoisin Belgium 13 198 0.7× 145 0.8× 77 0.6× 61 0.9× 68 1.5× 29 434
William R. Critchley United Kingdom 11 256 0.9× 62 0.4× 28 0.2× 65 1.0× 35 0.8× 35 411
Keld Sørensen Denmark 5 853 2.9× 547 3.2× 137 1.1× 88 1.3× 91 2.1× 6 1.1k
Eva Honsová Czechia 13 223 0.8× 242 1.4× 28 0.2× 83 1.2× 52 1.2× 32 478
Jason M. Gauthier United States 14 279 1.0× 102 0.6× 81 0.7× 36 0.5× 48 1.1× 29 415
Yousem Sa United States 12 244 0.8× 49 0.3× 171 1.4× 31 0.5× 159 3.6× 17 403
İlker İskender Canada 15 537 1.8× 132 0.8× 104 0.8× 48 0.7× 19 0.4× 31 657
Matthias Kapischke Germany 12 358 1.2× 38 0.2× 59 0.5× 69 1.0× 100 2.3× 33 505
Jin Sakamoto Japan 15 415 1.4× 69 0.4× 98 0.8× 58 0.9× 64 1.5× 44 540

Countries citing papers authored by R. Shorthouse

Since Specialization
Citations

This map shows the geographic impact of R. Shorthouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Shorthouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Shorthouse more than expected).

Fields of papers citing papers by R. Shorthouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Shorthouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Shorthouse. The network helps show where R. Shorthouse may publish in the future.

Co-authorship network of co-authors of R. Shorthouse

This figure shows the co-authorship network connecting the top 25 collaborators of R. Shorthouse. A scholar is included among the top collaborators of R. Shorthouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Shorthouse. R. Shorthouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Berry, Gerald J., et al.. (2000). IMMUNOSUPPRESSIVE THERAPIES FOR THE PREVENTION AND TREATMENT OF OBLITERATIVE AIRWAY DISEASE IN HETEROTOPIC RAT TRACHEA ALLOGRAFTS. Transplantation. 69(11). 2260–2266. 38 indexed citations
2.
Ikonen, Tuija, Tim Brazelton, Gerald J. Berry, R. Shorthouse, & Randall E. Morris. (2000). EPITHELIAL RE-GROWTH IS ASSOCIATED WITH INHIBITION OF OBLITERATIVE AIRWAY DISEASE IN ORTHOTOPIC TRACHEAL ALLOGRAFTS IN NON-IMMUNOSUPPRESSED RATS1. Transplantation. 70(6). 857–863. 52 indexed citations
5.
Reichenspurner, Hermann, Gerald J. Berry, Timothy R. Brazelton, et al.. (1997). OBLITERATIVE AIRWAY DISEASE AFTER HETEROTOPIC TRACHEAL XENOTRANSPLANTATION. Transplantation. 64(3). 373–383. 63 indexed citations
6.
7.
Cheung, Alfred K., et al.. (1997). Leflunomide abrogates accelerated heart allograft rejection in presensitized Rats. Transplantation Proceedings. 29(1-2). 1294–1295. 2 indexed citations
8.
Goldman, Mark E., Lynn J. Ransone, David W. Anderson, et al.. (1996). SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.. PubMed. 28(6). 3106–9. 11 indexed citations
9.
Cao, Wei, et al.. (1996). Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.. PubMed. 28(6). 3082–4. 22 indexed citations
10.
Gregory, Clare R., Xinfan Huang, Richard E. Pratt, et al.. (1995). TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENT. Transplantation. 59(5). 655–661. 183 indexed citations
11.
Gregory, Clare R., et al.. (1993). Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.. PubMed. 25(1 Pt 1). 120–1. 9 indexed citations
12.
Zheng, Binhai, et al.. (1991). Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.. PubMed. 23(1 Pt 1). 851–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026